Analytical Data
-
基因名
SLPI
- Application
-
别名
SLPI；WAP4；WFDC4；AntileukoProteinase
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P03973
-
表达区间
26-132aa
-
氨基酸序列
SGKSFKAGVCPPKKSAQCLRYKKPECQSDWQCPGKKRCCPDTCGIKCLDPVDTPNPTRRKPGKCPVTYGQCLMLNPPNFCEMDGQCKRDLKCCMGMCGKSCVSPVKA
-
分子量
16.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of SLPI (Secretory Leukocyte Protease Inhibitor) recombinant proteins has garnered significant interest due to the molecule's critical role in modulating immune responses and protecting epithelial tissues. SLPI is a serine protease inhibitor primarily expressed in epithelial cells, where it functions to inhibit various proteolytic enzymes, thereby preventing tissue damage during inflammation and infections. Its involvement in key biological processes, such as wound healing and microbial defense, has led researchers to explore its therapeutic potential in various conditions, including respiratory diseases, inflammatory disorders, and cancer. Recombinant SLPI production allows for the generation of high-purity proteins that can be used for functional studies, drug development, and potential clinical applications. Furthermore, the ability to engineer SLPI variants with enhanced properties offers opportunities for creating novel therapeutic agents with improved efficacy. As a result, the ongoing research into SLPI recombinant proteins aims not only to better understand their biological functions but also to leverage these insights for innovative treatment strategies in medicine.
